IDT

0.00%

11.0¢ idt australia limited

Ann: Trading Halt, page-158

First 158 Last

Share
Profile

Follow
bluekidds

116 Posts.

13

16/12/21

19:52

Post #: 58348883
Share

Originally posted by AussiePirate: ↑

I have been super bullish on IDT ever since March where I did some deep diving but the critical point yet to be mentioned here is, and I cannot express this enough... Moderna and Pfizer will not license their vaccine out to anyone! there are so many articles about them refusing to do so due to margin cuts on their profits etc. This is why Australia is trying to develop their own mRNA vaccine (the one Monash and IDT are working on) however they have not yet started phase 1 trials.

Novavax isn't yet FDA approved (they are hoping to be approved by end of the year) and even if they do get approved it is too late for any significant deal as gov has made their decision on Moderna... Obviously, the gov would have looked at multiple options but the best option right now must have been to allow Moderna to build and produce here with their own plant.

The best two outcomes of IDT right now are:
1: Novavax is approved before the new year / early next year by FDA and they allow the license of their vaccine to IDT for manufacture.

2: government gives some of the manufacturing grants to IDT (800 million) however these grants are shared and will be divided up so they aren't going to get 800 million. I would suspect 20% of IDT's market cap as that is the usual government handout.

I think outcome 1 is unlikely as IDT's plant is tiny and they are already working on the mRNA vaccine with Monash so CSL is more likely to get this job. Outcome 2 doesn't lead to anything except a strong cash balance unless they have a vaccine to manufacture which depends on outcome 1. Their in house vaccine won't be ready for one maybe two years at best.

I don't like to invest based on 'what if's.' Multiple approvals/ awards need to be put in motion in IDT's favour so if you are holding this based on a Novavax partnership then I think you are clutching at straws.

Gl to all

Expand

I totally agree with you and that's what I have been thinking as well. We shouldn't rely on manufacture for Novavax because our facility can't digest the amounts.

We should place ourself as professional small-scale mRNA manufacture, fill and finish to serve all Australian bio company to produce their vaccines. Monash will be one of the many.

IDT Price at posting: 29.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

RCE

Recce's R327 found effective against E.coli during clinical trial

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

Microcap Wrap: 5 explorers with news out today

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

There are more pages in this discussion • 2 more messages in this thread...

First 158 Last

Add IDT (ASX) to my watchlist

(20min delay)
Last 11.0¢		Change 0.000(0.00%)		Mkt cap ! $38.66M

Open	High	Low	Value	Volume
11.0¢	11.0¢	10.5¢	$11.44K	104.0K

Buyers (Bids)

No.	Vol.	Price($)
1	519	11.0¢

Sellers (Offers)

Price($)	Vol.	No.
11.5¢	149865	3

View Market Depth

No.	Vol.	Price($)
1	519	0.110
3	248400	0.105
4	1062473	0.100
1	15000	0.098
2	15500	0.096

Price($)	Vol.	No.
0.115	139865	2
0.120	106155	4
0.125	174981	2
0.130	101000	3
0.135	140000	2

Last trade - 16.10pm 28/06/2024 (20 minute delay)

IDT (ASX) Chart

Ann: Trading Halt, page-158

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Recce's R327 found effective against E.coli during clinical trial

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Ava Risk Group expands US presence with A$0.7M Substation Deal

Microcap Wrap: 5 explorers with news out today

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Trading Halt, page-158

Top Stories

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Recce's R327 found effective against E.coli during clinical trial

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Ava Risk Group expands US presence with A$0.7M Substation Deal

Microcap Wrap: 5 explorers with news out today

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News